These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione. Brandt ME; Puett D; Covey DF; Zimniski SJ J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962). Longcope C; Femino A; Johnston JO Endocrinology; 1988 May; 122(5):2007-11. PubMed ID: 3359974 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative. Zimniski SJ; Brandt ME; Covey DF; Puett D Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057 [TBL] [Abstract][Full Text] [Related]
11. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues. Marcotte PA; Robinson CH Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221 [TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489. di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584 [TBL] [Abstract][Full Text] [Related]
13. Substituted C19 steroid analogs as inhibitors of aromatase. Brueggemeier RW; Snider CE; Counsell RE Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196 [TBL] [Abstract][Full Text] [Related]
14. Interactions of thiol-containing androgens with human placental aromatase. Bednarski PJ; Nelson SD J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733 [TBL] [Abstract][Full Text] [Related]
15. Comparative studies of aromatase inhibitors in cultured human breast cancer cells. MacIndoe JH; Woods GR; Etre LA; Covey DF Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203 [TBL] [Abstract][Full Text] [Related]
16. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels. Brandt ME; Covey DF; Zimniski SJ J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521 [TBL] [Abstract][Full Text] [Related]
17. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione. Osawa Y; Osawa Y; Coon MJ Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372 [TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives. Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601 [TBL] [Abstract][Full Text] [Related]
19. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model. Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949 [TBL] [Abstract][Full Text] [Related]
20. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase. Covey DF; Hood WF Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]